Study types
- article 1
Condition tags
- disambig:endometritis 2
- endometriosis 1
- mesh:D004716 1
Top journals
Frequent coauthors
- Liu Y 4
- Zhang Y 3
- Dacheng Qu 2
- Zhou H 2
- You X 2
- Huang J 2
- Du C 1
- Jiang X 1
- Deng Q 1
- Junwen Chen 1
BackgroundTo investigate the impact of chronic endometritis (CE) on the recurrence of endometrial polyps (EPs) in premenopausal women after transcervical resection of endometrial polyps (TCRP).MethodsThis prospective study enrolled 507 wome…
BackgroundEctopic pregnancy (EP), reflecting a fertilized ovum implanted outside the normal uterine cavity, represents a frequent cause of morbidity and possibly mortality in women of reproductive age.ObjectiveTo summarize the diagnosis and…
BACKGROUND: The reported recurrence rate of endometrial polyps (EPs) after hysteroscopic polypectomy varied widely, and the factors influencing the recurrence of EPs are still controversial. Furthermore, the known definite independent risk …
Objective: To evaluate the impact of chronic endometritis (CE) on the recurrence of endometrial polyps (EPs) in premenopausal women who underwent hysteroscopic polypectomy. Methods: : We conducted a retrospective observational cohort study…
BackgroundPrevious reports have demonstrated two thiazolidione derivatives (H2-60 and H2-81) can robustly inhibit the planktonic growth and biofilm formation of S. epidermidis and S. aureus by targeting the histidine kinase YycG. Whereas th…
BackgroundA rapid development in assisted reproductive technology (ART) has led to a surge in its popularity among target couples. However, elucidation on the molecular mechanism and effective solutions for a common problem posed by ART, na…
ObjectiveTo verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels.DesignRetrospec…
ObjectiveTo evaluate the efficacy and safety of multiple- versus single-dose gonadotropin-releasing hormone agonist (GnRH-a) addition to luteal phase support (LPS), in patients with a first in vitro fertilization (IVF) failure associated wi…